MMCAP International Inc. SPC
Position in TDAC — Translational Development Acquisition Corp.
CIK 1304857
GRAND CAYMAN, E9
Position in TDAC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,703,000
+$31,500 QoQ
Shares Held
350,000
0.0% QoQ
Ownership
1.60%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TDAC Over Time
Shares Held
Position Value (USD)
Position in Shell Companies
Financial Services · as of Mar 31, 2026MMCAP International Inc. SPC holds $372,229,780 across 50 Shell Companies names. TDAC ranks #33 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DMII |
Drugs Made In America Acquisition II Corp.
|
2,700,000 | $26,919,000 | |
| 2 | NPAC |
New Providence Acquisition Corp. III/Cayman
|
2,200,000 | $22,572,000 | |
| 3 | FERA |
Fifth Era Acquisition Corp I
|
1,900,000 | $19,570,000 | |
| 4 | RDAG |
Republic Digital Acquisition Co
|
1,565,000 | $16,009,950 | |
| 5 | LPAA |
Launch One Acquisition Corp.
|
1,480,000 | $15,850,800 | |
| 6 | CEPF |
Cantor Equity Partners IV, Inc.
|
1,500,000 | $15,285,000 | |
| 7 | IPCX |
Inflection Point Acquisition Corp. III
|
1,400,000 | $14,301,000 | |
| 8 | GPAT |
GP-Act III Acquisition Corp.
|
1,275,000 | $13,821,000 |
All Filings in TDAC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,703,000 | 350,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,671,500 | 350,000 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,622,500 | 350,000 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||